EOCI has a demonstrated track record of over 13 years in the CME industry. Our reputation is a result of business integrity and professional agility, as well as resourcefulness and creativity.
In addition to the 25 to 30 CME programs we develop annually, EOCI produces other high-calibre specialist-focused annual congresses in Mont-Tremblant, and Montreal:
Dr. Stuart Connolly is a Professor of Medicine at McMaster University in Ontario and a Cardiac Electrophysiologist at Hamilton Health Sciences, Ontario, Canada.
Dr. Connolly holds a Masters degree from Fordham University, New York, USA and an MD from McGill University in Montreal, Canada. He received his specialist training in Cardiology at the University of Toronto, Canada and at Stanford University, USA. Dr. Connolly became a faculty member at McMaster University in 1983 and was awarded a full Professorship in 1994. As well as being an active Clinical Cardiologist, Dr. Connolly held the position of Director of the Division of Cardiology between 2005 and 2015. He was also appointed as the inaugural holder of the Salim Yusuf Chair in Cardiology at McMaster University during that time. His main research interests include the evaluation of treatments for heart rhythm disorders, and his academic career has been largely dedicated to the design and execution of controlled clinical trials in this area.
Dr. Connolly is an Editorial Board member for a number of prominent Cardiology journals, including Heart, the Journal of Pacing and Electrophysiology, and Journal of the American College of Cardiology. He has also authored and co-authored more than 345 scientific articles in the field.
Dr. Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute.
Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He completed training in Internal Medicine, Clinical Pharmacology, and Cardiology at the University of Toronto and completed a Fellowship in Cardiac Electrophysiology at Stanford University.
He is a recipient of the University of Toronto Department of Medicine Research Award, and the Canadian Cardiovascular Society Achievement Award.
He is the Past-President of the Canadian Heart Rhythm Society, Chairman of the Cardiac Arrest Committee, St. Michael’s Hospital, Co-PI on the NIH funded Resuscitation Outcomes Consortium, head of the cardiac arrest committee of the Canadian Resuscitation Outcomes Consortium, and serves on the steering committee of multiple multicenter clinical trials in arrhythmia care. He is the Chair of the Canadian Cardiovascular Society Quality Committee.
His research interests include resuscitation science, sports cardiology, arrhythmias in athletes, basic science research in advanced cardiac life support and atrial fibrillation, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.
He was the principal investigator of the ALIVE RCT of antiarrhythmic drugs in cardiac arrest, the Family study on predicting and preventing sudden cardiac death , the CIHR funded EpiDOSE RCT, and the Program to reduce sudden death funded by the Canadian Arrhythmia Network.
He has published over 400 peer reviewed papers and is Associate Editor of the textbook Electrophysiological Disorders of the Heart.
Dr. L. Brent Mitchell obtained his BSc (Hon) in Biochemistry (1972) and his MD (1975) from the University of Calgary. After a Fellowship in Clinical Cardiology at Dalhousie University in Halifax, he undertook a Fellowship in Clinical Cardiac Electrophysiology at Stanford University Medical Center in California. He returned to Calgary in 1982. Dr. Mitchell is the former Head of the Department of Cardiac Sciences at the University of Calgary/Calgary Zone of Alberta Health Services, and the former Director of the Libin Cardiovascular Institute of Alberta.
Dr. Joseph Minkowitz joined the Markham Stouffville Hospital in 1990, after completing his Cardiology training in the University of Toronto’s Adult Cardiology Program. Living in a demographically diverse multiethnic area, he is constantly exposed to complex divergent medical pathologies with multifaceted socioeconomic overtones. During the past decade, the paradigm of tertiary cardiology services has shifted from academia to the community. As Lead Cardiologist of a non-tertiary care hospital, Dr. Minkowitz’s goal was to define the centrality of cardiology services in the community by emphasizing the continuum of care between inpatient and outpatient services. The recently inaugurated cardiac clinic enables rapid access for low-risk patients discharged from the ER, post-intervention patients, newly diagnosed heart failure patients and new onset atrial fibrillation patients, minimizing wait times and catching those who have fallen through the cracks while awaiting cardiology referral. At the same time, Dr. Minkowitz is aware that maintaining strong partnerships and relationships with tertiary care and academic centres ensures the delivery of state-of-the-art guideline-derived medical therapy.
Dr. Adrian Baranchuk, a native of Buenos Aires, Argentina, obtained his MD from the University of Buenos Aires in 1990. After qualifying in Internal Medicine and Cardiology (1995), he completed a Clinical Fellowship in Cardiac Electrophysiology (1997). In 2002, he immigrated to Spain, where he did a Research Fellowship. Dr. Baranchuk was appointed a Clinical Fellow in Electrophysiology at McMaster University in September 2003.
Dr. Baranchuk was appointed an Assistant Professor of Medicine at Queen’s University (2006), and was promoted to Associate Professor in 2010 and to Full Professor in 2016. He founded the EP Training Program in 2007.
He is a member of numerous editorial boards and a reviewer of several journals. He received a teaching award (Outstanding Contribution in the Core Internal Medicine Program, 2009) and the Faculty of Health Sciences Education Award in 2014.
Dr. Baranchuk was awarded the Golden Caliper Award by SOLAECE (Latin American Society of Pacing and Electrophysiology) in 2014 for his outstanding contributions to science, and the ISHNE Junior Investigator Award in April 2015.
His first book, Atlas of Advanced ECG Interpretation (Remedica , UK), represents a major collaboration of well-recognized electrophysiologists from around the world. His second book, Left Septal Fascicular Block, was released by Springer in 2016. His last iBook, Electrocardiography in Practice: What to do? was the no. 1 seller on iTunes for several weeks in 2016.
Dr. Baranchuk has published more than 425 articles in well-recognized international journals (321 in PubMed), as well as 40 book chapters. He has also presented more than 220 abstracts. He is President Elect of the International Society of Electrocardiology (ISE) for 2017-2019.
He lives in Kingston, Ontario, with his wife Barbara and his daughter Gala.
Dr. Elaine Gordon graduated from McMaster Medical School in 1977 and trained in Medicine and Cardiology at the University of Toronto and Stanford University. She is currently Associate Professor of Medicine at McMaster University and Director of the Adult Congenital Cardiac Clinic and Special Cardiac Pregnancy Clinic at McMaster Medical Centre.
Dr. Sonia Anand is a Professor of Medicine and Epidemiology at McMaster University, the Director of the Population Genomics Program and a vascular medicine specialist at Hamilton Health Sciences and McMaster University. She holds the Canada Research Chair in Ethnic Diversity and Cardiovascular Disease. She also holds the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. Her present research focuses upon the environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.
Dr. Anand received a Doctor of Medicine from McMaster in1992, Internal Medicine Training at McMaster and a Fellowship of the Royal College of Physicians and Surgeons of Canada in 1996. She further received her Master’s in Clinical Epidemiology at McMaster in 1996 and Ph.D. in Health Research Methodology at McMaster in 2002. In 1996, Dr. Anand received a Canadian Institutes of Health Research Clinician Scientist Award Phase 1 followed by the Phase 2 Award which she held from 2003-2008. Her current research includes leading cohort studies including two birth cohorts - one among South Asian women of the greater Toronto area and the second among Indigenous women from the Six Nations Reserve. Further she is a co-PI of the Canadian Alliance of Health Hearts and Minds cohort study funded by the Canadian Partnership Against Cancer and Heart and Stroke Foundation of Canada. Her work is widely published amongst academic and peer-evaluated journals and she teaches clinical epidemiology courses in methodology and cardiovascular disease at McMaster University.
Dr. David Birnie was appointed Staff Cardiac Electrophysiologist at the University of Ottawa Heart Institute in May 2002. He was educated in Scotland and received his medical degree (MB ChB) from Glasgow University in 1990. After completion of Internal Medical training at Aberdeen University he gained his MRCP (UK) in 1993. He spent three years as a cardiology research fellow at Glasgow University from 1993 studying the immunology of atherosclerosis and was awarded his PhD equivalent (MD) in 1996. Between 1996 and 2001 he did cardiology training at Glasgow University and received his Certificate of Completion of Specialist Cardiology Training in 2001. In addition, he spent a year in 1999-2000 as a Cardiac Electrophysiology Fellow at the Ottawa Heart Institute.
Dr. Birnie is the Director of the Arrhythmia Services at UOHI. His clinical focus is on all aspects of cardiac electrophysiology including arrhythmia pharmacotherapy and radiofrequency ablation of simple and complex arrhythmias including atrial fibrillation. He also has a major clinical interest in all aspects of implantation and follow-up of device therapy for arrhythmias. To date he has been involved in over 400 peer-reviewed presentations, publications, and book chapters. His major ongoing research interests are selection and optimization of CRT for heart failure patients, investigating optimal strategies for stroke reduction around device surgery and following AF ablation and cardiac sarcoidosis. He has current peer reviewed funding from CIHR and Heart and Stroke Foundation of Canada. He has recently managed to combine work with his major passion/hobby; serving as cardiologist for the Medical Advisory Committee of the Canadian Soccer Association.
Dr. Hisham Dokainish completed his undergraduate education and medical school at McMaster University, followed by Internal Medicine and Cardiology residency programs at the University of Ottawa. After completing an Echocardiography Fellowship at Vancouver General Hospital in 2002, he was hired as a faculty member at Baylor College of Medicine in Houston, Texas. He then returned to Canada in 2009 as Associate Professor of Medicine at McMaster University and Director of Echocardiography, as well as Director of the Medical Diagnostic Unit and Director of the Heart Failure Clinic at Hamilton Health Sciences. His interests include echocardiography, diastolic heart failure and valve disease. His sees outpatients in the new Cardiac Ambulatory Clinic at the Hamilton General Hospital, and is active in teaching and research at Hamilton Health Sciences/McMaster University.
John Eikelboom, MBBS, MSc, FRCPC is Associate Professor in the Department of Medicine, McMaster University, and haematologist in the Thrombosis Service, Hamilton General Hospital, Ontario, Canada. He originally trained in Internal Medicine and Haematology in Perth, Australia and subsequently moved to Hamilton to take up a Tier II Canada Research Chair in Cardiovascular Medicine. Dr. Eikelboom has co-authored more than 500 articles in peer-reviewed journals. His current research, supported by the Canadian Institutes for Health Research, the Heart and Stroke Foundation and the National Health and Medical Research Council of Australia, focuses on the efficacy and safety of antithrombotic therapies, outcomes after blood transfusion and bleeding, and the mechanisms of variable response to antiplatelet drugs.
Dr David Fitchett graduated from Cambridge University in the UK in 1970, and continued his clinical training at The Middlesex Hospital Medical School, London. His cardiology training was at The Brompton and Hammersmith Hospitals where he completed his MD thesis in Clinical and Experimental Studies of Heart Muscle Disorders. In 1978 he went to The Royal Victoria Hospital, Montreal where he was director of the CCU and medical director of the cardiac transplant program.
He is a fellow of the American College of Cardiology, The European Society of Cardiology and ofthe Royal College of Physicians of Canada.
In 1997 he came to St Michael's Hospital in Toronto as Director of the
Cardiac ICU. He remained in that role until2008.
Dr Fitchett has over 350 reviewed publications, abstracts, and book chapters. He is a reviewer for many journals including the New England Journal of Medicine, Circulation, American Heart Journal, Nature Medicine, and the Canadian Journal of Cardiology. His current research interests are clinical trials in acute coronary syndromes, and cardiovascular outcomes in diabetes.
He was the chair of the macrovascular section of the 2013 Canadian Diabetes Guidelines. He is on the steering and on data and safety committees for several international clinical trials.
Currently Dr Fitchett is an Associate Professor of Medicine at the University of Toronto and a Staff Cardiologist at St Michael's Hospital.
Jacques Genest obtained his MD at McGill University and did a residency in Internal Medicine at McGill then a cardiology fellowship at Tufts University in Boston. He did Post-doctoral studies in Boston in lipoprotein metabolism and molecular genetics at Tufts University. Since 2000, he is Professor of Medicine and holds the McGill/Novartis Chair in Medicine at McGill. From 2000-10, he was Head of Cardiology at McGill University. He is currently Scientific Director of the Center for Innovative Medicine at the McGill University Health center (MUHC).
His research focuses on the metabolic and genetic basis of premature coronary artery disease and the role of high density lipoproteins (HDL) in atherosclerosis.
Dr. Jean C. Grégoire received his MD from the University of Montréal in 1985. He performed his residency in Internal Medicine and Cardiology in 1990 at the same University. He completed training in interventional cardiology at the Quebec Heart Institute, followed by two years of animal model study of coronary restenosis after angioplasty and endothelial dysfunction at the Mayo Clinic, Rochester, Minnesota.
He is an Associate Clinical Professor at the University of Montreal and works in the Interventional Cardiology Service, Coronary Care Unit, and in clinical research at the Montreal Heart Institute. He is the author of several book chapters and scientific publications. He is Co-President of the Canadian Cardiovascular Society Dyslipidemia Guidelines and member of CHEP. His principal research interests include the role of oxidative stress in atherosclerosis and restenosis post angioplasty, endothelial dysfunction, inflammation, new biomarkers, atherosclerotic plaque imaging, dyslipidemia, diabetes, hypertension and acute coronary syndrome.
Jeff Healey is the director of arrhythmia services at Hamilton Health Sciences, Professor of medicine at McMaster University and the Population Health Research Institute Chair in Cardiology Research. He is also the principal investigator and chair of the Canadian Stroke Prevention Intervention Network (CSPIN), which is conducting a series of clinical trials related to atrial fibrillation and stroke prevention and will also support the development of new Canadian researchers in this field. He is the past co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee and past chair of the Cardiac Care Network of Ontario’s Heart Rhythm Working group.
Dr. Healey was the lead author of the ASSERT trial, which was published in the New England Journal of Medicine in 2012 and demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers. Thomson-Reuters recognized ASSERT as the 38th most-cited scientific publication in 2012. He was also the lead author of the SIMPLE trial, published in the Lancet in 2015, which demonstrated that implantable defibrillators could be safely inserted without performing intra-operative defibrillation testing, and the RELY AF cohort study, a 15,000-patient worldwide registry, published in the Lancet in 2016, examining the causes, treatment and outcomes in patients with atrial fibrillation.
Dr Gabrielle Horne, MBBS, PhD, MRCP(UK), FRCPC, is a cardiologist at the QEII Health Sciences Centre in Halifax, and an Associate Professor of Medicine and Biomedical Engineering at Dalhousie University. She has a PhD in physiology from the University of Calgary and obtained her clinical and post-doctoral training in London UK, Calgary, Halifax and Indianapolis. She has been a staff cardiologist at Dalhousie University and at the QEII Health Sciences Centre since 1998. She has the privilege of coordinating the Maritime Connective Tissue Clinic, which provides multidisciplinary care to patients and families with genes that cause aneurysms. The Clinic has received two Leading Practice awards from Accreditation Canada, and the was the overall winner for Innovation in the Public Sector awarded by Progress Magazine (based in Atlantic Canada) in 2014.
Dr. George J. Klein is currently Professor of Medicine at Western University in London, Ontario, Canada. He received his medical degree in 1972 at the University of Toronto. He received his certification from The Royal College of Physicians and Surgeons of Canada in Internal Medicine in 1976 and in Cardiology in 1978. He has been an Honorary Lecturer in the Department of Physiology at Western University since 1993. He was an Ontario Career Investigator with the Heart and Stroke Foundation of Ontario from 1987 to 1989. He received the Canadian Cardiovascular Society Research Achievement Award in 1988 (Cardiac Arrhythmias: From the Bench to the Operating Theater). The Heart and Stroke Foundation of Ontario honored him with a Distinguished Research Professorship award from 1989-1994.
His research focus has been in cardiac arrhythmia with contributions to the natural history and management of the Wolff-Parkinson-White syndrome, the operative and ablative management of arrhythmias and the understanding of clinical syncope. He is the inventor of the implantable loop recorder (Reveal rx). He is deputy editor of the Journal of Cardiac Electrophysiology (JCE), Associate Editor of Pacing and Clinical Electrophysiology (PACE) and is on the Editorial Board of seven scientific journals. He served on the Test Committee for cardiac electrophysiology of the American Board of Internal Medicine (ABIM) from 1996 to 2005 and was Chair of the Committee from 2000 to 2005. He was the 2003 recipient of the Distinguished Teacher Award of the North American Society for Pacing and Electrophysiology (now known as “Heart Rhythm Society”). He was a recipient of a Queen Elizabeth II Diamond Jubilee Medal in 2012 in recognition of his contributions to medicine in Canada. He has supervised the arrhythmia training of 65 Research Fellows over the years, published 6 books, 87 book chapters and 537 papers and currently holds 12 US patents.
Dr. Andrew D. Krahn is a Professor in the Division of Cardiology at the University of British Columbia. He received his MD from the University of Manitoba. His clinical expertise is in the management of cardiac arrhythmias. Current research interests include investigation of genetic causes of arrhythmia, causes of loss of consciousness and implantable arrhythmia device monitoring.
Dr. Krahn’s research is funded by the Heart and Stroke Foundation and the Canadian Institutes of Health Research. His research has been published in scientific journals such as Circulation, JAMA, the Journal of the American College of Cardiology, the New England Journal of Medicine, Heart Rhythm, the Journal of Cardiovascular Electrophysiology, the European Heart Journal, the American Journal of Medicine, the American Heart Journal, the American Journal of Cardiology, the Canadian Journal of Cardiology and the Canadian Medical Association Journal. He has published 305 papers and 290 abstracts in peer-reviewed journals. He is an associate editor at Heart Rhythm, and sits on the editorial board of Heart Rhythm, the Canadian Journal of Cardiology and the Journal of Cardiovascular Electrophysiology.
Dr. Krahn is affiliated with several professional associations, including the Royal College of Physicians of Canada, the Canadian Cardiovascular Society and the Heart Rhythm Society. He is a member of the Canadian Cardiovascular Society Council. He is the Sauder Family Chair and UBC Chief of Cardiology and the Paul Brunes Chair in Heart Rhythm Disorders. He is also on the board of trustees of the Heart Rhythm Society. His major clinical interests are the inherited heart rhythm clinic and arrhythmia device management.
He is married with a 23-year-old daughter who has just completed her degree in fine arts (www.artbykassondra.com), and enjoys skiing, basketball, golf and a good glass of red wine.
Dr. G.B. John Mancini is a tenured Professor of Medicine at the University of British Columbia, and directs an imaging-based research program (Cardiovascular Imaging Research Core Laboratory, CIRCL) that includes facilities for quantitative coronary angiography, ultrasound analysis (coronaries, carotids and brachial artery for atherosclerosis and endothelial function assessments) and cardiac computed tomography analysis. Dr. Mancini remains in active practice as a staff physician in the Vancouver Hospital Cardiology Outpatient Clinic and the Cardiac Computed Tomography Program, as well as the St. Paul’s Hospital Healthy Heart Prevention Program/Lipid Clinic.
Dr. Mancini received his MD degree from the University of Toronto, completed his residency at Toronto General Hospital and was a Cardiology and Research Fellow at the University of California at San Diego. After a year as Clinical Assistant Professor at U.C. San Diego, he joined the faculty of the University of Michigan, where he became Associate Chief of Cardiology and Chief of the V.A. Section of Cardiology in 1987. He was Chair of Medicine at the University of British Columbia from 1992 to 2002. He is a Fellow of the American College of Cardiology, Governor of the American College of Cardiology (British Columbia) and a member of the Circulation Council of the American Heart Association; he is also a member of numerous other professional associations in the United States and Canada. Dr. Mancini is a Past President of the Canadian Society for Clinical Investigation and current President of the Medical/Allied Staff of Vancouver Hospital. He has published over 250 journal articles, abstracts, books and book chapters. He serves as a reviewer for many journals, and is currently a member of the editorial boards of the American Journal of Cardiology, the Canadian Journal of Cardiology and the International Journal of Cardiac Imaging.
Dr. Mancini is currently Coordinating Investigator for the Cardiovascular Imaging Research Core Laboratory for numerous multi-centred trials. His areas of special interest include digital angiography, quantitative coronary angiography, quantitative intravascular ultrasound, quantitative carotid ultrasound, cardiac computed tomography, coronary flow reserve/fractional flow reserve, endothelial dysfunction, primary and secondary CV risk reduction and regression of atherosclerosis.
Dr. Gary Raskob's research and scholarly interests are in the prevention, diagnosis and treatment of deep-vein thrombosis and pulmonary embolism; the clinical development of antithrombotic drugs; clinical trials; prevention research; evidence-based medicine; and the translation of research evidence into practice and health policy.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology, the American College of Chest Physicians, the American Thoracic Society, and the American Society of Clinical Oncology. He also serves as an advisor on thrombosis and hemostasis for the U.S. National Heart, Lung, and Blood Institute, and the Centers for Disease Control and Prevention. Dr. Raskob is author or coauthor of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 16 articles in the New England Journal of Medicine.
Receive the latest news on the Arrhythmia Update Conference directly in your mailbox.